Publications by authors named "Lisa Berquist"

Claim this Profile
G
Galiximab (anti-CD80)-induced growth inhibition and prolongation of survival in vivo of B-NHL tumor xenografts and potentiation by the combination with fludarabine.
Kandasamy Hariharan, Peter Chu, Tracey Murphy, Dana Clanton, Lisa Berquist

Int J Oncol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an Fn14 agonistic antibody as an anti-tumor agent.
Jennifer S Michaelson, Aldo Amatucci, Rebecca Kelly, Lihe Su, Ellen Garber, Lisa Berquist

MAbs· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A stable IgG-like bispecific antibody targeting the epidermal growth factor receptor and the type I insulin-like growth factor receptor demonstrates superior anti-tumor activity.
Jianying Dong, Arlene Sereno, Dikran Aivazian, Emma Langley, Brian R Miller, Lisa Berquist

MAbs· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stable IgG-like bispecific antibodies directed toward the type I insulin-like growth factor receptor demonstrate enhanced ligand blockade and anti-tumor activity.
Jianying Dong, Arlene Sereno, William B Snyder, Brian R Miller, Susan Tamraz, Lisa Berquist

J Biol Chem· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of inhibitory anti-insulin-like growth factor receptor antibodies with different epitope specificity and ligand-blocking properties: implications for mechanism of action in vivo.
Adam Doern, Xianjun Cao, Arlene Sereno, Christopher L Reyes, Angelina Altshuler, Lisa Berquist

J Biol Chem· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis